Enfortumab vedotin-induced cutaneous toxic effects are linked to improved survival in patients with advanced bladder cancer, a cohort study shows.

Women with obesity who completed supervised physical activity programs — whether face-to-face or digital — showed marked improvements in self-esteem and body image, with most gains emerging in the ...

From per diem shifts to solo practice, physicians share the benefits and costs of working less and living more.

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Doctors who study ‘medical humanities’ have gained a deeper grasp of how classic works influence and intertwine with modern practice. And they’re better doctors for it.

Patients requiring intensive care for COVID pneumonia have reduced exercise capacity and more frequent restrictive pulmonary function patterns in the early post-COVID period.

Circulating endotrophin rises with fat gain and falls with fat loss, showing promise as a biomarker of body fat changes and a potential target for reducing obesity-linked health risks.

Recently approved nonhormonal options can help manage a range of symptoms, and potential new treatments are gaining momentum.

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Among advanced therapies for Crohn's disease, adalimumab is linked to a higher chance of maintaining clinical remission.

Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.